Research
Hormonal
GLP-1 receptor agonists lower plasma glucose and suppress appetite, providing significant benefits for glycemic control and weight loss in type 2 diabetes and obesity.
If you have type 2 diabetes or obesity, GLP-1 receptor agonists are a proven, first-line treatment option that effectively lowers blood sugar and aids weight loss. Discuss these options with your healthcare provider to see if they are appropriate for your specific health profile.
StrongSupportsVERY_HIGH confidence
GLP-1 receptor agonists are now widely used in the treatment of type 2 diabetes and obesity, delivering significant benefits in glycemic control, weight loss, and cardiovascular protection.
Why this rating
The paper is a comprehensive review in Physiological Reviews citing widespread clinical use and significant benefits.
Source
Proglucagon-derived peptides: human physiology and therapeutic potential
Lærke S. Gasbjerg et al. · Physiological Reviews · 2025
narrative_reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →